Invitae Corporation
NVTA
Rank in Stocks
#35740
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Share Price
$0.016
Last synced: 2024-03-11
Market Cap
$3.27M
Change (1 day)
-5.33%
Change (1 year)
5,233.33%
Country
US
Trade Invitae Corporation (NVTA)
Category
Healthcare
Stock price history for Invitae Corporation (NVTA)
Highest end of day price: $0.00 on 2024-08-01
Lowest end of day price: $19.17 on 2015-02-01
Lowest end of day price: $19.17 on 2015-02-01
Stock price history of Invitae Corporation from 2015 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2024 | -99.95% |
| 2023 | -71.56% |
| 2022 | -86.50% |
| 2021 | -67.85% |
| 2020 | 194.07% |
| 2019 | 47.18% |
| 2018 | 31.94% |
| 2017 | 20.96% |
| 2016 | -6.63% |
| 2015 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.25 | 50.06% |
CN
|
|
| $177.93 | 21.98% |
US
|
